In Pfizer Win, PTAB Says Rival's Gene Therapy Wasn't New
The Patent Trial and Appeal Board has sided with arguments from Pfizer that two of a rival's patents covering a new kind of experimental gene therapy to treat hemophilia failed to contain...To view the full article, register now.
Already a subscriber? Click here to view full article